Compare · CARL vs MDLN
CARL vs MDLN
Side-by-side comparison of Carlsmed Inc. (CARL) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CARL and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $45.28B, about 163.3x CARL ($277.3M).
- Over the past year, CARL is down 29.4% and MDLN is down 15.4% - MDLN leads by 13.9 points.
- MDLN has been more active in the news (21 items in the past 4 weeks vs 1 for CARL).
- MDLN has more recent analyst coverage (25 ratings vs 5 for CARL).
PerformanceCARL-18.25%MDLN-15.42%
2025-12-17+0.00%2026-06-03
- Company
- Carlsmed Inc.
- Medline Inc.
- Price
- $10.21-0.29%
- $34.47+3.78%
- Market cap
- $277.3M
- $45.28B
- 1M return
- +11.83%
- -22.04%
- 1Y return
- -29.37%
- -15.42%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2025
- News (4w)
- 1
- 21
- Recent ratings
- 5
- 25
Latest CARL
- Carlsmed Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 10-Q filed by Carlsmed Inc.
- Carlsmed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Carlsmed® Reports First Quarter 2026 Financial Results
- Carlsmed, Inc. To Participate in Upcoming Investor Conferences
- SEC Form DEFA14A filed by Carlsmed Inc.
- SEC Form DEF 14A filed by Carlsmed Inc.
- Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026
- Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference
- CEO, President Cordonnier Michael exercised 391,686 shares at a strike of $0.68 and sold $2,629,889 worth of shares (197,855 units at $13.29), increasing direct ownership by 14% to 1,550,477 units (SEC Form 4)
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)